LV10580B - Pharmaceutical composition and process - Google Patents

Pharmaceutical composition and process Download PDF

Info

Publication number
LV10580B
LV10580B LVP-94-150A LV940150A LV10580B LV 10580 B LV10580 B LV 10580B LV 940150 A LV940150 A LV 940150A LV 10580 B LV10580 B LV 10580B
Authority
LV
Latvia
Prior art keywords
tricalcium phosphate
weight
bone
isopropoxyisoflavone
hydroxylapatite
Prior art date
Application number
LVP-94-150A
Other languages
English (en)
Latvian (lv)
Other versions
LV10580A (lv
Inventor
Prezmeczky Laszlo
Klenk Gusztav
Englovszky Erzsebet
Horvath Tibor
Miszkiewicz Laszlo
Szekacs Gabor
Levai Ferenc
Vitanyi-Nee-Morvai Magdolna
Original Assignee
Chinoin Gyegyszer S Vegy Szeti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyegyszer S Vegy Szeti filed Critical Chinoin Gyegyszer S Vegy Szeti
Publication of LV10580A publication Critical patent/LV10580A/xx
Publication of LV10580B publication Critical patent/LV10580B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00—Preparations for dentistry
    • A61K6/50—Preparations specially adapted for dental root treatment
    • A61K6/54—Filling; Sealing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00—Preparations for dentistry
    • A61K6/60—Preparations for dentistry comprising organic or organo-metallic additives
    • A61K6/69—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00—Preparations for dentistry
    • A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
    • A61K6/831—Preparations for artificial teeth, for filling teeth or for capping teeth comprising non-metallic elements or compounds thereof, e.g. carbon
    • A61K6/838—Phosphorus compounds, e.g. apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02—Inorganic materials
    • A61L27/12—Phosphorus-containing materials, e.g. apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/432—Inhibitors, antagonists
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Transplantation (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Plastic & Reconstructive Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Dental Preparations (AREA)
LVP-94-150A 1993-08-02 1994-07-29 Pharmaceutical composition and process LV10580B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9302230A HU212932B (en) 1993-08-02 1993-08-02 Parmaceutical composition containing ipriflavone, hydroxyapatit and tricalciumphosphate for treating lack of bones and process for producing the composition

Publications (2)

Publication Number Publication Date
LV10580A LV10580A (lv) 1995-04-20
LV10580B true LV10580B (en) 1995-10-20

Family

ID=10983854

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-94-150A LV10580B (en) 1993-08-02 1994-07-29 Pharmaceutical composition and process

Country Status (14)

Country Link
US (1) US5571186A (de)
EP (1) EP0638321B1 (de)
JP (1) JP3500190B2 (de)
KR (1) KR950005313A (de)
CN (1) CN1208093C (de)
AT (1) ATE188129T1 (de)
AU (1) AU686632B2 (de)
CA (1) CA2129279A1 (de)
DE (1) DE69422346T2 (de)
DK (1) DK0638321T3 (de)
ES (1) ES2142893T3 (de)
HU (1) HU212932B (de)
LV (1) LV10580B (de)
NZ (1) NZ264152A (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU9502198D0 (en) * 1995-07-21 1995-09-28 Chinoin Gyogyszer Es Vegyeszet Novel indication
CN101646433B (zh) 2006-10-24 2011-11-16 戴维·W·克雷姆平 抗再吸收的和造骨的食物增补剂和使用方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3949085A (en) * 1970-05-27 1976-04-06 Chinoin Gyogyszer-Es Vegyeszeti Termakek Gyara Rt Anabolic-weight-gain promoting compositions containing isoflavone derivatives and method using same
HU162377B (de) * 1970-05-27 1973-02-28
JPS59199630A (ja) * 1983-04-26 1984-11-12 Takeda Chem Ind Ltd 卵巣機能低下症治療剤
HU199444B (en) * 1985-09-10 1990-02-28 Chinoin Gyogyszer Es Vegyeszet Process for producing 7-isopropoxy-isoflavone-cyclodextrene inclusion complex and pharmaceutical compositions therefrom
HU201474B (en) * 1987-02-03 1990-11-28 Tibor Balogh Process for producing new dentriatrical composition
US5124325A (en) * 1989-06-13 1992-06-23 Kyorin Pharmaceutical Co., Ltd. Therapeutic agents of metabolic bone disease
IT1241079B (it) * 1990-03-23 1993-12-29 Chiesi Farma Spa Composizioni farmaceutiche contenenti ipriflavone,procedimento per la loro preparazione e relativo impiego terapeutico
US5164187A (en) * 1990-04-05 1992-11-17 Norian Corporation Hydroxyapatite prosthesis coatings
IT1244697B (it) * 1991-02-01 1994-08-08 Chiesi Farma Spa Associazione farmaceutica per la prevenzione e il trattamento dell'osteoporosi post-menopausale

Also Published As

Publication number Publication date
NZ264152A (en) 1996-08-27
AU686632B2 (en) 1998-02-12
EP0638321A1 (de) 1995-02-15
JPH07144018A (ja) 1995-06-06
DE69422346T2 (de) 2000-07-27
EP0638321B1 (de) 1999-12-29
CN1105271A (zh) 1995-07-19
JP3500190B2 (ja) 2004-02-23
LV10580A (lv) 1995-04-20
KR950005313A (ko) 1995-03-20
ES2142893T3 (es) 2000-05-01
HUT71253A (en) 1995-11-28
HU9302230D0 (en) 1993-10-28
AU6881094A (en) 1995-02-09
DK0638321T3 (da) 2000-06-19
CN1208093C (zh) 2005-06-29
HU212932B (en) 1996-12-30
DE69422346D1 (de) 2000-02-03
US5571186A (en) 1996-11-05
CA2129279A1 (en) 1995-02-03
ATE188129T1 (de) 2000-01-15

Similar Documents

Publication Publication Date Title
Rocci et al. Immediate loading of Brånemark System® TiUnite™ and machined‐surface implants in the posterior mandible: a randomized open‐ended clinical trial
Minamizato et al. Clinical application of autogenous partially demineralized dentin matrix prepared immediately after extraction for alveolar bone regeneration in implant dentistry: a pilot study
Norton et al. Dental implants placed in extraction sites implanted with bioactive glass: human histology and clinical outcome.
Schepers et al. Bioactive glass particles of narrow size range: a new material for the repair of bone defects
Scheller et al. A 5-year multicenter study on implant-supported single crown restorations.
Stahl et al. Histological evaluation of human intraosseous healing responses to the placement of tricalcium phosphate ceramic implants: I. Three to eight months
Froum et al. Histological comparison of healing extraction sockets implanted with bioactive glass or demineralized freeze‐dried bone allograft: A pilot study
Maiorana et al. Alveolar socket preservation with demineralised bovine bone mineral and a collagen matrix
Nevins et al. Human histologic evaluation of bioactive ceramic in the treatment of periodontal osseous defects.
Foreman et al. A review of calcium hydroxide
Adell et al. A 15-year study of osseointegrated implants in the treatment of the edentulous jaw
Iasella et al. Ridge preservation with freeze‐dried bone allograft and a collagen membrane compared to extraction alone for implant site development: A clinical and histologic study in humans
Cochran et al. Evaluation of recombinant human bone morphogenetic protein‐2 in oral applications including the use of endosseous implants: 3‐year results of a pilot study in humans
Hartwell et al. Healing of furcation perforations in primate teeth after repair with decalcified freeze-dried bone: a longitudinal study
Froum et al. Human Intraosseous Healing Responses to the Placement of Tricalcium Phosphate Ceramic Implants: II. 13 to 18 Months
JPS5813523B2 (ja) ハノ シヨチヨウジユウテンマタハ ヒフクザイリヨウ
De Wijs et al. Front tooth replacement with Tübingen (Frialit®) implants
Parodi et al. Use of Emdogain in the treatment of deep intrabony defects: 12-month clinical results. Histologic and radiographic evaluation.
Alhadainy et al. Use of a hydroxylapatite-based material and calcium sulfate as artificial floors to repair furcal perforations
Rossmeisl et al. A study of freeze-dried (lyophilized) cortical bone used as an apical barrier in adult monkey teeth
US5571186A (en) Pharmaceutical bone growth-promoting composition and process
Prakash et al. Osteogenic potential of tooth as autogenous bone graft in dental extraction sites: A split-mouth randomized controlled human trial
Gerner et al. External root resorption in patients with secondary bone‐grafting of alveolar clefts
Nemcovsky et al. Modern clinical procedures in periodontal reconstructive treatment
RU2114601C1 (ru) Способ лечения заболеваний пародонта